Using Dysport® with bracing to treat adolescent idiopathic scoliosis
Official title: Dysport ® (abobotulinumtoxinA) as an Adjunctive Treatment to Bracing in the Management of Adolescent Idiopathic Scoliosis
Run by Johns Hopkins University · NCT03935295 · Data updated 2026-11-12
This study is testing if using Dysport® injections along with a brace can help kids aged 10-16 with scoliosis have better results and prevent their spine from getting worse.
Quick facts
| Phase | Phase 4 |
|---|---|
| Study type | Interventional |
| Ages | 10 Years to 16 Years |
| Sex | All |
| Enrollment | 90 (estimated) |
| Sponsor | Johns Hopkins University Academic / other |
| Locations | 1 site (Baltimore, Maryland) |
| Status | Recruiting |
| Started | September 3, 2020 |
| Main results expected | December 31, 2026 |
| Study ends | December 31, 2026 |
| Registry record updated | December 9, 2025 |
| Trial ID | NCT03935295 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are skeletally immature children aged 10-16 years with idiopathic scoliosis, a major curve of 20°-40°, and who can adhere to a bracing protocol.
✕Probably not a fit
Patients with congenital or neuromuscular scoliosis, previous spinal surgery, or those currently requiring surgery will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates the effectiveness of botulinum toxin A (Dysport®) as an adjunctive treatment alongside bracing for children with adolescent idiopathic scoliosis (AIS). It involves administering Dysport® injections into the paraspinal muscles of the concave side of the major curve in skeletally immature patients aged 10-16 years. The study compares outcomes between patients receiving Dysport® and those receiving a placebo, both while adhering to a bracing protocol. The goal is to determine if Dysport® can reduce curve progression and improve the effectiveness of bracing in managing AIS.
Why it matters
Potential benefit: If successful, this approach could establish a new standard of nonoperative care for adolescent idiopathic scoliosis, potentially reducing the need for surgical interventions.
How similar studies have gone: While there is limited research on the use of botulinum toxin as an adjunct therapy in scoliosis treatment, this approach is novel and has not been extensively tested in prior studies.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion criteria: * Clinically determined idiopathic nature of scoliosis * Age 10-16 years * Risser stage 0,1,or 2 * major curve of 20°-40° * curve apex caudal to T7 vertebra * ability to adhere to bracing protocol * Botulinum toxin naïve or previously treated greater than 6 months prior to study entry Exclusion criteria: * Diagnosis of congenital scoliosis, neuromuscular scoliosis, or other "reason" for scoliosis - Previous surgery at any segment of the spine * Current need for surgery at any level of the spine * Treatment with any drug known to interfere with neuromuscular function * Any other medical condition, laboratory or diagnostic procedure finding that might preclude administration of BTX * Ongoing infection at the injection sites * Diagnosis as either resistant or sensitive to botulinum toxin treatment of any type or to any components of the BTX formulation * Cow milk protein allergy
Where it's running
-
Johns Hopkins University
Baltimore, Maryland, United States Recruiting
Study contacts
- Principal investigator: Paul Sponseller, MD, MBA — Johns Hopkins Hospital Department of Orthopaedic Surgery
- Study coordinator: Gabrielle Reichard, MA
- Email: greicha1@jhmi.edu
- Phone: 4105023626
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Comfort Tote to help recovery after scoliosis surgery in teens
This study tests whether a therapeutic Comfort Tote can reduce pain and anxiety after surgery for adolescent idiopathic scoliosis.
-
Erector spinae plane block to reduce post-operative pain after posterior spinal fusion in children
This will try giving an erector spinae plane block with ropivacaine to see if it reduces pain and the need for opioid pain medicine after posterior spinal fusion in children with adolescent idiopathic or neuromuscular scoliosis.
-
MRI-guided dynamic support for correcting adolescent scoliosis
This pilot tests whether an MRI-compatible air-padded support with programmable pneumatic control can quickly reduce spinal curvature in 10–16-year-olds with mild to moderate adolescent idiopathic scoliosis.
-
Detecting scoliosis progression without X-rays using Momentum Spine app
This study tests whether the Momentum Spine app can reliably detect scoliosis progression in 8-18 year olds without radiographs and guide follow-up care.
-
Examining how spinal manipulation affects motor control in adolescents with scoliosis
This study is testing how spinal manipulation affects movement control in teenagers with scoliosis to see if it helps them improve their balance and muscle function.
-
Using a 3D camera to assess scoliosis in adolescents
This study is testing a new way to check the spine of teenagers with scoliosis using a special 3D camera to see if it’s better and safer than traditional X-rays.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.